According to a new market report published by Lucintel, the future of the drug screening market looks promising with opportunities in the workplace, criminal justice systems and law enforcement agencies, drug treatment centers, pain management centers, hospitals, and drug testing laboratories. The drug screening market is expected to grow with a CAGR of 10% from 2019 to 2024. The major drivers for this market are growing drug and alcohol consumption, enforcement of stringent laws mandating drug and alcohol testing, and presence of government funding in major markets.

In this market, analytical instruments, rapid testing devices, and drug screening service are used to screen the drug. Rapid testing devices segmented into urine testing devices and oral fluid testing devices where oral fluid testing device is expect to have highest CAGR during the forecast period.

Urine, breath, oral fluid, hair, other samples are the used to determine the drug screening. Oral fluid is the largest sample segment of the drug screening market.
North America will remain the largest region over the forecast period due to rising consumption of illicit drugs, availability of government funding to curb drug abuse, and the presence of laws supporting drug screening, and growing burden of accidents due to unsafe levels of alcohol consumption. large amount of drug abuse and adoption of drug screening devices in the region.
Alere, Thermo Fisher Scientific, Drägerwerk, Labcorp, Quest Diagnostics, Alfa Scientific Designs, Lifeloc, MPD, Orasure, Omega Laboratories, Premier Biotech, Psychemedics, Roche, Shimadzu, and Siemens Healthineers are among the major manufacturers of drug screening.
Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the drug screening market by product and service, sample type, end user, and region. Lucintel has prepared a comprehensive research report titled " Drug Screening Market 2019-2024: Trends, Forecast, and Opportunity Analysis". The Lucintel report serves as a catalyst for growth strategy as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes a forecast for the drug screening market by product and service, sample type, end user, and region as follows:
By Product and Service [$M shipment analysis for 2013 – 2024]:
• Analytical Instruments
• Rapid Testing Devices
• Drug Screening Services
By Sample Type [$M shipment analysis for 2013 – 2024]:
• Urine
• Breath
• Oral Fluid
• Hair
• Other Samples
By End User [$M shipment analysis for 2013 – 2024]:
• Workplace
• Criminal Justice Systems and Law Enforcement Agencies
• Drug Treatment and Pain Management Centers
• Hospitals
• Others
By Region [$M shipment analysis for 2013 – 2024]:
• North America
o United States
o Canada
o Mexico
• Europe
o United Kingdom
o Germany
o France
o Italy
o Spain
• Asia-Pacific
o China
o India
o Japan
• ROW
o Brazil
A report of more than 150 pages will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link…… or [email protected].
About Lucintel
Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting, M&A, and due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.
This report addresses the following key questions:
Q.1. What are some of the most promising potential, high-growth opportunities for the drug screening market by product and service (analytical instruments, rapid testing devices, and drug screening services), sample type (urine, breath, oral fluid, hair, and other samples), end user (workplace, criminal justice systems and law enforcement agencies, drug treatment centers and pain management centers, hospitals, and others (schools, colleges, and individual users), and region (North America, Europe, Asia-Pacific, and ROW)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which regions will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the drivers and challenges of the drug screening market?
Q.5. What are the business risks and threats to the drug screening market?
Q.6. What are emerging trends in this drug screening market and the reasons behind them?
Q.7. What are some changing demands of customers in the drug screening market?
Q.8. What are the new developments in the drug screening market? Which companies are leading these developments?
Q.9. Who are the major players in this drug screening market? What strategic initiatives are being implemented by key players for business growth?
Q.10. What are some of the competitive products and processes in this drug screening area and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11. What M & A activities have taken place in the last 5 years in drug screening market?